Air France KLM Martinair Cargo upgrades Schiphol pharma hub to transport COVID-19 vaccines

Air France-KLM

Air France KLM Martinair Cargo (AFKLMP Cargo) is constructing a brand-new climate-cool room at its Schiphol Pharma Hub, a new step in preparation for the distribution of Covid-19 vaccines, which will be handled by a dedicated task force. The additional cold room (COL), with temperatures ranging from +2°C to +8°C, will provide the capacity required to handle Covid-19 vaccines.

Using the latest technology, AFKLMP Cargo will offer:

  • Additional 2,061 m cu in storage space
  • Dangerous Goods and DRY ICE compatible service
  • Additional 152 skid positions
  • Flexible temperature range
  • Flexible racks to accommodate odd-sized shipments
  • Monitoring from a central control room
  • Temperature alarm system
  • Speed door to limit exposure
  • Synthetic floor

Enrica Calonghi, global head of Pharmaceutical Logistics at AFKLMP Cargo: “Just a few months ago, AFKLMP Cargo already invested in 1,118 m cu of additional controlled-climate room (CRT) at Schiphol using the same hybrid technology. With the construction of this brand-new climate-cool room, we will be as flexible as possible to handle more vaccines if necessary.”

Shipping pharma and healthcare products is a core activity for AFKLMP Cargo, the company is continuously improving its services and investing in infrastructure at its Paris Charles de Gaulle (CDG) and Amsterdam Schiphol (AMS) hubs.

Customers can therefore book their valuable pharma via our myCargo portal, where the company offers clarity on capacity, infrastructure and capabilities at the CDG and AMS hubs, but also at more than 120 pharma destinations worldwide.

Source: Air France KLM

SUBSCRIBE TO LOGISTICS BRIEFING:

Get the latest logistics news and high level analysis delivered straight to your inbox:

  • Create a password
  • By clicking submit you consent to creating a Logistics Briefing account